Founded in 1996 - CNS focus - Validated tests - Quality - Customers - Publications
 Therapeutic area - Methods - Disease Models - Programs - Research Collaboration Contract Research - Research Partner - Research Collaboration - QA Program - Confidentiality and IP Rights Sign-up for mailing list - Examples of newsletters Contact us Search engineSITE MAP
PRECLINICAL RESEARCH
neurofit@neurofit.com

Tel :
+33 (0)3 88 65 16 06

 Fax :
 +33 (0)3 88 65 16 22

NEUROFIT

Boulevard Sébastien Brant
BIOPARC - Parc d'Innovation - 67400 ILLKIRCH
FRANCE
NEUROFIT is a leading provider of pre-clinical research services for central and peripheral nervous system disorders and oncology.
NEUROFIT offers an extensive repertoire of validated screening tests for psychiatric, neurological, ophthalmological disorders and in oncology. All steps of the process are regulated according to our extensive Quality Assurance Program.
Examples of Screening Tests
Anxiety:
 Light-dark test
 Elevated plus maze
Marble burying test
Parkinson disease :
 In Vitro MPP+ model
Neuropathy :
 Diabetic neuropathy
Cognition :
 T-maze Continuous Alternation Task (T-CAT)
... See more under Services
T-maze Coutinuous Alternation Task (T-CAT)
Nicotine
Donepezil
Nicotine or Donepezil reverses the cognitive deficit as reflected by the increase in the spontaneous alternation of scopolamine-treated mice in the T-maze.
MK-801
PCP
MK-801 or PCP induced deficit as well as aging-related deficit are also available.


Reversion of scopolamine-induced deficit
by Nicotine in Swiss mice


Reversion of scopolamine-induced deficit
by Donepezil in Swiss mice